Skip to main content Accessibility help
×
Home

Investigation and management of the unknown primary with metastatic neck disease: United Kingdom National Multidisciplinary Guidelines

  • K Mackenzie (a1), M Watson (a2), P Jankowska (a3), S Bhide (a4) and R Simo (a5)...

Abstract

This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. It discusses the evidence base pertaining to the management of metastatic neck disease in the setting of an unknown primary and provides recommendations on the work up and management for this group of patients receiving cancer care.

Recommendations

  • All patients presenting with confirmed cervical lymph node metastatic squamous cell carcinoma and no apparent primary site should undergo:
    • Positron emission tomography-computed tomography whole-body scan. (R)
    • Panendoscopy and directed biopsies. (R)
    • Bilateral tonsillectomy. (R)
  • Tongue base mucosectomy can be offered if facilities and expertise exists. (G)
  • Concomitant chemotherapy with radiation should be considered in patients with an unknown primary. (R)
  • Concomitant chemotherapy with radiation should be offered to suitable patients in the post-operative setting, where indicated. (R)
  • Neo-adjuvant chemotherapy can be used in gross ‘unresectable’ disease. (R)
  • Patients should be followed up at least two months in the first two years and three to six months in the subsequent years. (G)
  • Patients should be followed up to a minimum of five years with a prolonged follow up for selected patients. (G)
  • Positron emission tomography–computed tomography scan at three to four months after treatment is a useful follow-up strategy for patients treated by chemoradiation therapy. (R)

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Investigation and management of the unknown primary with metastatic neck disease: United Kingdom National Multidisciplinary Guidelines
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Investigation and management of the unknown primary with metastatic neck disease: United Kingdom National Multidisciplinary Guidelines
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Investigation and management of the unknown primary with metastatic neck disease: United Kingdom National Multidisciplinary Guidelines
      Available formats
      ×

Copyright

This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.

Corresponding author

Address for correspondence: K MacKenzie, Glasgow Royal Infirmary, University of Glasgow, Glasgow, UK E-mail: Kenneth.MacKenzie@glasgow.ac.uk

References

Hide All
1 Strojan, P, Ferlito, A, Medina, JE, Woolgar, JA, Rinaldo, A, Robbins, KT et al. Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck 2013;35:123–32
2 Yeo, JC, Lim, SY, Hilmi, OJ, MacKenzie, K. An analysis of non-head and neck primaries presenting to the neck lump clinic: our experience in two thousand nine hundred and six new patients. Clin Otolaryngol 2013;38:429–32
3 Krane, JF. Role of cytology in the diagnosis and management of HPV-associated head and neck carcinoma. Acta Cytol 2013;57:117–26
4 Sivars, L, Nasman, A, Tertipis, N, Vlastos, A, Ramqvist, T, Dalianis, T et al. Human papillomavirus and p53 expression in cancer of unknown primary in the head and neck region in relation to clinical outcome. Cancer Med 2014;3:376–84
5 Kwee, TC, Kwee, RM. Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis. Eur Radiol 2009;19:731–44
6 Zhu, L, Wang, N. 18F-fluorodeoxyglucose positron emission tomography–computed tomography as a diagnostic tool in patients with cervical nodal metastases of unknown primary site: a meta-analysis. Surg Oncol 2013;22:190–94
7 Karni, RJ, Rich, JT, Sinha, P, Haughey, BH. Transoral laser microsurgery: a new approach for unknown primaries of the head and neck. Laryngoscope 2011;121:1194–201
8 Graboyes, EM, Sinha, P, Thorstad, WL, Rich, JT, Haughey, BH. Management of human papillomavirus-related unknown primaries of the head and neck with a transoral surgical approach. Head Neck 2015;37:1603–11
9 Nagel, TH, Hinni, ML, Hayden, RE, Lott, DG. Transoral laser microsurgery for the unknown primary: role for lingual tonsillectomy. Head Neck 2014;36:942–6
10 Durmus, K, Patwa, HS, Gokozan, HN, Kucur, C, Teknos, TN, Agrawal, A et al. Functional and quality-of-life outcomes of transoral robotic surgery for carcinoma of unknown primary. Laryngoscope 2014;124:2089–95
11 Mehta, V, Johnson, P, Tassler, A, Kim, S, Ferris, RL, Nance, M et al. A new paradigm for the diagnosis and management of unknown primary tumors of the head and neck: a role for transoral robotic surgery. Laryngoscope 2013;123:146–51
12 Strojan, P, Ferlito, A, Langendijk, JA, Corry, J, Woolgar, JA, Rinaldo, A et al. Contemporary management of lymph node metastases from an unknown primary to the neck: II. A review of therapeutic options. Head Neck 2013;35:286–93
13 Dragan, AD, Nixon, IJ, Guerrero-Urbano, MT, Oakley, R, Jeannon, JP, Simo, R. Selective neck dissection as a therapeutic option in management of squamous cell carcinoma of unknown primary. Eur Arch Otorhinolaryngol 2014;271:1249–56
14 Bernier, J, Domenge, C, Ozsahin, M, Matuszewska, K, Lefèbvre, JL, Greiner, RH et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945–52
15 Demiroz, C, Vainshtein, JM, Koukourakis, GV, Gutfeld, O, Prince, ME, Bradford, CR et al. Head and neck squamous cell carcinoma of unknown primary: neck dissection and radiotherapy or definitive radiotherapy. Head Neck 2014;36:1589–95
16 Daly, PE, McArdle, O, Armstrong, JG, Yau, J, Pinto, H, Kaplan, M et al. Can we avoid bilateral radiation therapy in head and neck carcinoma of unknown primary in the PET–CT era? Int J Radiat Oncol Biol Phys 2012;84:S250
17 Cooper, JS, Pajak, TF, Forastiere, AA, Jacobs, J, Campbell, BH, Saxman, SB et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937–44
18 Frank, SJ, Rosenthal, DI, Petsuksiri, J, Ang, KK, Morrison, WH, Weber, RS et al. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson cancer center outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 2010;78:1005–10
19 Richards, TM, Bhide, SA, Miah, AB, Schick, U, Gujral, DM, Newbold, K et al. Phase 2 trial of total mucosal and bilateral neck intensity modulated radiotherapy in squamous cell cancer of unknown primary. Eur J Can 2011;47:S559
20 Shoushtari, A, Saylor, D, Kerr, KL, Sheng, K, Thomas, C, Jameson, M et al. Outcomes of patients with head-and-neck cancer of unknown primary origin treated with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2011;81:e8391
21 Pignon, JP, le Maitre, A, Maillard, E, Bourhis, J, Group, M-NC. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17 346 patients. Radiother Oncol 2009;92:414
Type Description Title
PDF
Full supplement PDF

Full supplement PDF
Full supplement PDF

 PDF (10.5 MB)
10.5 MB

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed